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ABSTRACT
Control of RNA processing plays a major role in
HIV-1 gene expression. To explore the role of
several hnRNP proteins in this process, we carried
out a siRNA screen to examine the effect of deple-
tion of hnRNPs A1, A2, D, H, I and K on HIV-1 gene
expression. While loss of hnRNPs H, I or K had little
effect, depletion of A1 and A2 increased expression
of viral structural proteins. In contrast, reduced
hnRNP D expression decreased synthesis of HIV-1
Gag and Env. Loss of hnRNP D induced no changes
in viral RNA abundance but reduced the accumula-
tion of HIV-1 unspliced and singly spliced RNAs in
the cytoplasm. Subsequent analyses determined
that hnRNP D underwent relocalization to the cyto-
plasm upon HIV-1 infection and was associated with
Gag protein. Screening of the four isoforms of
hnRNP D determined that, upon overexpression,
they had differential effects on HIV-1 Gag expres-
sion, p45 and p42 isoforms increased viral Gag syn-
thesis while p40 and p37 suppressed it. The
differential effect of hnRNP D isoforms on HIV-1 ex-
pression suggests that their relative abundance
could contribute to the permissiveness of cell
types to replicate the virus, a hypothesis subse-
quently confirmed by selective depletion of p45
and p42.
INTRODUCTION
Replication of HIV-1 is dependent upon the activity of
multiple host factors (1). This point is particularly appar-
ent for viral RNA processing (splicing, polyadenylation,
transport and translation). From a single 9-kb primary
transcript, over 30 mRNAs are generated to permit ex-
pression of all of the viral reading frames; Gag and
GagPol proteins from the unspliced (US) RNA, Vif/
Vpr/Vpu/Env from the singly spliced (SS, 4kb) RNAs
and Tat/Rev/Nef from the 1.8kb, multiply spliced (MS)
RNAs (2). The protein expressed within each class of viral
RNAs is determined by the speciﬁc 30-splice sites used to
generate the mRNA. In turn, splice-site selection is based
on both the strength of the splice site (the polypyrimidine
tract and branchpoint sequence) as well as the activity of
adjacent exon splicing silencers (ESSs) and exon splicing
enhancers (ESEs) that inhibit or enhance, respectively use
of the adjacent 30-splice sites (3). Disruption of some of the
cis-acting elements can lead to a profound inhibition of
virus replication suggesting that these processes are at-
tractive targets for therapeutic intervention (4).
Given the known and putative role of hnRNPs in
regulating RNA metabolism (5), it is of interest to
evaluate members of this family for their role in regulating
HIV-1 gene expression. Previous studies have already
identiﬁed hnRNP A/B, and H proteins as having roles
in regulating function of HIV-1 ESSs (3,6). Using both
in vitro splicing assays and model substrates in transient
transfection assays, several laboratories have demon-
strated that hnRNP A1 binds to multiple ESS elements
within the viral genome to inhibit use of the adjacent 30-ss
(7–12). In the case of hnRNP H, in vitro assays have
indicated that it binds ESS2p to modulate use of the
30-ss for Tat (13). In contrast to hnRNP A1 and H,
hnRNP A2 has been implicated in viral RNA transport,
depletion of the protein resulting in accumulation of viral
genomic RNA in regions near or at the microtubule
organizing centers (14,15). Immunoprecipitation con-
ﬁrmed interaction of hnRNP A2 with HIV-1 genomic
RNA and sequence analysis identiﬁed two regions
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binding sites, mutation of one leading to alterations
in Gag expression (14,15). hnRNP E1 was shown to
affect viral gene expression but, in this instance, it acts
to alter the translation efﬁciency of the US and SS
HIV-1 mRNAs (16).
To further characterize the function of various hnRNPs
in the control of HIV-1 expression, we used siRNAs to
deplete individual factors in cells containing an integrated
form of the HIV-1 provirus, resembling the state during
natural infection. Cells were subsequently monitored for
changes in Gag and Env protein expression as well as the
corresponding RNAs. Of the six factors analyzed
(hnRNPs A1, A2, D, H, I, K), only three were observed
to have a signiﬁcant effect: depletion of hnRNPs A1 or A2
increased levels of the HIV-1 structural proteins (Gag,
Env) while reduction in hnRNP D levels decreased syn-
thesis of Gag and Env. Subsequent analysis of viral RNAs
revealed that each factor affected different steps in HIV-1
RNAs metabolism, hnRNP A1 affecting splice-site selec-
tion, hnRNP A2 altering abundance of US viral RNA and
hnRNP D being required for efﬁcient cytoplasmic accu-
mulation of US and SS viral RNAs. Interestingly, infec-
tion with HIV-1 was observed to result in a signiﬁcant
shift in hnRNP D subcellular distribution (from predom-
inately nuclear to cytoplasmic) that involved one of the
isoforms of this protein (p42). Analysis of individual
hnRNP D isoforms revealed that two (p37, p40) inhibited
while the other two (p42 and p45) increased Gag expres-
sion from the integrated provirus. This latter ﬁnding sug-
gested that, by varying the relative abundance of hnRNP
D isoforms, one can render the cell permissive or
non-permissive for the replication of HIV-1. This hypoth-
esis was conﬁrmed by demonstrating that selective deple-
tion of p45 and 42 hnRNP D isoforms also resulted in loss
of HIV-1 structural protein expression.
MATERIALS AND METHODS
Plasmids
FSGagGFP HIV proviral construct was provided by
Chen Liang (McGill University). HIV-rtTA(G19F E37L
P56K) proviral construct was obtained from A. Das and
B. Berkhout (University of Amsterdam) (17,18). HIV
Hxb2 R-/RI- was generously provided by Eric Cohen
(Universite de Montreal). LAI MLS and HIVMls
rtTA were generated by digestion with Mls1 and ligating
the plasmid backbone closed, deleting the RT and IN
reading frames. Flag tagged expression vectors for
hnRNP D/AUF1 p37, p40, p42 and p45 were obtained
from Robert Schneider (Rockefeller University) (19).
Cell lines
HeLa FSGagGFP cell lines were generated by infection of
cells with pseudotyped virions generated by transfection of
293T cells with FSGagGFP, VSV G expression vector and
pPAX2 packaging constructs. Transduced cells were
isolated using FACS for high GFP expression. Isolated
cells were expanded and selection for GFP expression
repeated another six times to generate the line used.
To generate the HeLa rtTA HIVmls cell line, the
HeLa rtTA cell line was infected with virus generated by
transfection of 293T cells with HIVmls rtTA, pPAX2
and VSV G expression vector. Stably transduced cell
clones were screened for doxycycline-dependent Gag
expression and the B2 clone selected for subsequent
studies (20).
RNAi/overexpression assays
For depletion of indicated hnRNP proteins, HeLa
FSGagGFP cells were transfected with the indicated
siRNA (Table 1) at a concentration of 80nM using
Oligofectamine (Invitrogen) according to manufacturer’s
protocol. At 72h post-transfection, cells were harvested
and used for protein/RNA analysis. To analyze the effect
of protein overexpression, HeLa HIVmls rtTA cells were
transfected with expression plasmid for secreted alkaline
phosphatase (CMV SEAP), Tet transactivator (CMV
tTA) (21) and vectors expressing FLAG tagged hnRNP
D p37, p40, p42 or p45. About 48–72h post-transfection,
cells were harvested and analyzed for protein and RNA.
Cell supernatants were collected and analyzed for SEAP
expression by colorimetric assay or HIV p24 levels by
ELISA.
Protein analysis
To analyze the effect of siRNA treatment on target
protein expression, cell extracts were fractionated on
SDS–PAGE gels and transferred onto PVDF membranes.
Blots were subsequently probed for the protein of
interest. Antibodies used were as follows; tubulin
(Sigma, cat. #T9026), hnRNP A1, A2 and H antibodies
were provided by Benoit Chabot (Universite ´ de
Sherbrooke), hnRNP D/AUF1 antibody from Upstate
(cat. #07-260) or William Rigby (Dartmouth Medical
School), hnRNP K from K. Bomsztyk (University of
Washington), hnRNP I/PTB from D. Black (UCLA).
To conﬁrm hnRNP D overexpression, blots were probed
with anti-FLAG antibody (Sigma, cat. #F1804). To detect
alterations in HIV-1 gene expression, blots were probed
with anti-gp160 antibody (Chessie 8, NIH AIDS reagent
program), HIV-1 Rev antibody (abcam cat. #ab855290),
GFP antibody [Novus Biologicals, cat. #NB600-303), or
anti-p24 monoclonal antibody (NIH AIDS reagent
program clone 183-H12-5C, kindness of Bruce Chesebro
(22)]. To analyze the effect of siRNA treatment on viral
particle production, cell supernatants were collected at the
same time cell extracts were prepared. The amount of
GagGFP/Gag released was quantitated using p24
ELISA kits obtained from the AIDS and Cancer Virus
Program as per manufacturer’s instructions.
To evaluate the interaction of hnRNP D with HIV-1
Gag, HeLa cells were transfected with pcDNA3.1 or
pNL4.3-WT using Lipofectamine 2000 (Invitrogen).
About 24h post-transfection, cells were washed two
times with ice-cold 1  PBS, and lysed in buffer containing
50mM Tris–HCl pH7.5; 5mM EDTA pH 8.0; 100mM
NaCl; 1mM DTT; 0.5% NP-40 and Complete Protease
Inhibitor (Roche). Cell lysates were clariﬁed by centrifu-
gation at 18000 ga t4  C and then precleared for
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mixtures were then centrifuged for 10min and supernatant
were collected in new tubes. Half of each of the samples
was incubated with 10ml of RNase A (Sigma Aldrich) for
30min on ice. Precleared lysates (+/  RNase A) were
diluted with 1  PBS to a ﬁnal concentration of 1.0mg/
ml and incubated with rabbit anti-hnRNP D antibody for
24h at 4 C. Protein A-agarose was added to the lysates
and mixtures were incubated for 2h at 4 C. Beads were
washed three times with 10mM Tris–HCl pH8, 150mM
NaCl, 0.1% NP40. hnRNP D-associated proteins were
separated on SDS–PAGE and HIV-1 Gag detected using
mouse monoclonal anti-p24 antibody (clone 183-H12-5C).
To assess the effect of HIV-1 expression on AUF-1 lo-
calization, HeLa cells were transfected with pcDNA3 or
pNL4.3-WT proviral DNA. Cells were harvested 24h
post-transfection and ﬁxed with 4% paraformaldehyde,
1  PBS. Combined IF/FISH analyses were performed
as described in Lehmann et al. (23). After FISH with a
digoxigenin-labeled probe, US HIV-1 RNA was visualized
by staining with biotinylated anti-digoxigenin (Sigma-
Aldrich), following by secondary anti-biotin monoclonal
antibody conjugated with Alexa Fluor 488 (Invitrogen).
hnRNP D/AUF1 was recognized using primary rabbit
anti- hnRNP D/AUF1 antibody that was detected with
donkey anti-rabbit Alexa Fluor 594 (Invitrogen). Gag
molecules were stained with primary sheep anti-p17
antibody (from Michael Phelan, NIH AIDS Reference
and Reagent Program) that was detected with secondary
donkey anti-sheep Alexa Fluor 647 (Invitrogen). Laser
scanning confocal microscopy (LSCM) was performed at
1024 1024 pixel resolution using a Zeiss Pascal LSM5
(Carl Zeiss, Germany). To verify the immunoﬂuorescence
observation, cell fractionation was performed in parallel
as previously described (24). To verify purity of cell frac-
tions, blots were probed with antibody to GAPDH
(Techni-Science, Montreal, QC) or nucleolin (Santa Cruz
Biotechnology, Inc.) as cytoplasmic and nuclear markers,
respectively.
RNA analysis
Changes in HIV-1 US, SS and MS RNAs abundance were
quantitated by qRT–PCR. RNA was extracted from cell
pellets using guanidine thiocyanate extraction (25) or Bio
Rad total RNA extraction kits. An amount of 3mg of total
RNA was subsequently treated with Turbo DNAse
(Ambion) to remove residual DNA then an aliquot used
for cDNA synthesis. DNase-treated RNA samples were
incubated with 1  ﬁrst strand buffer (Sigma-Aldrich),
0.25mM dNTPs, 0.1mg/ml random hexamers, 0.4U
reverse transcriptase at 37 C for 1h in a total volume of
20ml. Upon completion, reaction was diluted to 75ml with
water and 5ml used for qPCR. The following primer pairs
were used: US HIV-1 RNA, F 50-GAC GCT CTC GCA
CCC ATC TC-30,R ,5 0-CTG AAG CGC GCA CGG
CAA-30; single spliced HIV-1 RNA, F 50-GGC GGC
GAC TGG AAG AAG C-30,R5 0-CTA TGA TTA
CTA TGG ACC ACA C-30; MS HIV-1 RNA, F
50-GAC TCA TCA AGT TTC TCT ATC AAA-30,R
50-AGT CTC TCA AGC GGT GGT-30; actin mRNA, F
50-GAG CGG TTC CGC TGC CCT GAG GCA CTC-30,
R5 0-GGG CAG TGA TCT CCT TCT GCA TCC TG-30.
Reactions contained 1  Thermopol buffer (NEB),
0.25mM dNTPs, 1 unit SYBRgreen, 0.4U Taq polymer-
ase. Reactions were run on Eppendorf Realplex4
mastercycler, data analyzed by Realplex software and all
values normalized to a standard curve of untreated
sample.
To analyze effects of hnRNP depletion on splice-site
selection, the PCR protocol of Purcell et al. was used
(26). In the ﬁrst stage reaction, 1ml of cDNA was
incubated with 1  Thermpol buffer (Roche), 0.25mM
dNTPS, 1mM forward and reverse primer and 1U Taq
polymerase. For 2-kb RNAs, primers used were ODP 45
(50-CTG AGC CTG GGA GCT CTC TGG C-30) and
ODP 32 (50-CCG CAG ATC GTC CCA GAT AAG-30).
For analyzing 4kb RNAs, primers used were ODP45 and
ODP 84 (50-TCA TTG CCA CTG TCT TCT GCT CT-30).
Cycle conditions were 10 at 94 C, 10 at 57 C and 10 at
68 C. Reactions were run for 25 cycles. Labeling of the
amplicons was achieved by additional rounds of ampliﬁ-
cation in the presence of
32P a dCTP. In brief, amplicons
were diluted 10-fold (1.8kb RNAs) or added straight (4kb
RNAs) to a second reaction identical to the ﬁrst stage
with the addition of 1mCi
32P a dCTP to the reaction
cocktail. Reactions were run for ﬁve cycles then products
analyzed on 8M urea, 7% PAGE gels. Gels were subse-
quently dried and analyzed using a phosphorimager.
Quantitation was carried out using ImageQuant software.
To assay effects of hnRNP depletion on viral RNA
subcellular distribution, cells were fractionated into
nuclear and cytoplasmic fractions by lysis in RSB-100
(10mM Tris–HCl pH 7.4, 10mM NaCl, 2.5mM MgCl2,
1U/ml RNaseOUT, 40mg/ml digitonin (Calbiochem).
Cytoplasmic fractions were collected following
Table 1. siRNA sequences used for hnRNP depletion
Target mRNA Top strand Bottom strand
hnRNP A1 50-CUUUGGUGGUGGUCGUGGATT-30 50-UCCACGACCACCACCAAAGTT-30
HnRNP A2 50-AAGCUUUGAAACCACAGAAGATT-30 50-UCUUCUGUGGUUUCAAAGCUUTT-30
HnRNP D exon 7 50-CUGGAACCAGGGAUAGUTT -30 50-ACUAUAUCCCUGGUUCCAGTT -30
HnRNP D 50AGACUGCACUCUUGAAGUUATT-30 50-UAACUUCAGAGUCAGUCUTT-30
HnRNP H 50-GCACAGGUAUAUUGAAAUCTT-30 50-GAUUUCAAUAUACCUGUGCTT-30
HnRNP I/PTB 50-CCGAGAAGAAUAAAGAGGCTT-30 50-GCCUCUUUAUUCUUCUCGGTT-30
HnRNP K 50-UGAUACUCAAUAUGCGCUCTT-30 50-GAGCGCAUAUUGAGUAUCATT-30
Nucleic Acids Research,2012, Vol.40, No. 8 3665centrifugation at 2000 g for 10min. and RNA
precipitated from this fraction by addition of sodium
acetate to 0.3M and three volumes of ethanol.
Following incubation on dry ice, RNA was pelleted and
dissolved in RNA extraction buffer (Bio Rad Total RNA
extraction kit). Nuclear pellets were washed with RSB-100
buffer, pelleted and then dissolved in the RNA extraction
buffer. Following puriﬁcation, the level of speciﬁc RNAs
was determined by qRT–PCR as outlined above.
To assay effects of hnRNP D isoforms on stability of
HIV-1 RNAs, HeLa rtTA HIVmls cell line transfected
with hnRNP D/AUF1 expression vectors were treated
with 50mg/ml a amanitin for indicated times before
harvest and RNA extraction. Levels of individual RNAs
were quantitated by qRT–PCR as described above using
18S rRNA abundance to normalize for cDNA synthesis
efﬁciency between samples.
RESULTS
Depletion of hnRNP A1, A2, or D alter HIV-1
gene expression
To analyze the effect of depleting targeted hnRNPs on
HIV-1 RNA processing and expression, we elected to
use a cell line stably transduced with a replication
inactive HIV-1 provirus (FSGag GFP) in which GFP
has been fused to the C-terminus of Gag (deleting both
PR and RT domains of Pol) (Figure 1A). To select for
stably transduced cells, multiple rounds of FACS were
carried out to obtain a cell line expressing GagGFP
(Supplementary Figure S1). To verify that the selection
process did not skew the pattern of HIV-1 gene expres-
sion, cells were analyzed by northern/western blotting and
RT–PCR and results compared to cells transiently trans-
fected with the FSGagGFP vector (Supplementary
Figures S1 and S2). Analyses indicate that the pattern of
RNA expression (as assessed by northern blots and RT–
PCR analysis of 1.8- and 4-kb RNAs) was similar to the
transiently transfected samples and splice site use similar
to viruses containing the complete viral genome (Hxb2 R-/
RI-) or having major deletions within the pol reading
frame (LAIMLS) (Supplementary Figure S2). Western
blots also conﬁrmed GagGFP and gp160/gp120 ex-
pression in the stably transduced cells (Supplementary
Figure S1).
Having characterized the cell line, attention turned
to establishing conditions for hnRNP depletion. As
shown in Figure 1B, depletion of the targeted hnRNPs
was achieved under the selected conditions. Of the four
possible hnRNP D isoforms that have been described
(p45, p42, p40 and p37), western blot indicated that p45,
p42 and p40 were the dominant isoforms present in
this cell line. To assess possible negative effects of deple-
tion of individual hnRNPs on cell function, treated
cells were analyzed for changes in growth rate and levels
of apoptosis. With the exception of siRNA directed
against hnRNP A1 and K, none of the siRNAs reprodu-
cibly altered either the growth rate (data not shown) or
level of staining with annexin V/7 AAD (Supplementary
Figure S3).
Once conditions for depletion of selected hnRNP
proteins were established, the effects on HIV-1 gene ex-
pression were assessed by western blotting and p24
ELISA. As outlined in Figure 1C, depletion of hnRNP
A1and A2 were observed to increase HIV-1 gp160/gp120
(Env) and p55 (Gag) expression, with loss of hnRNP A2
having the greatest effect. In contrast, loss of hnRNP D/
AUF1 reduced expression of HIV-1 structural proteins
(Env, Gag). Depletion of hnRNP H, I, or K had no de-
tectable effect on HIV-1 gene expression. Analysis of
secreted GagGFP (p24 ELISA) from treated cells
(Figure 1D) yielded a similar pattern of response, deple-
tion of hnRNP A1 and A2 yielding increases in Gag pro-
duction while loss of hnRNP D resulted in a reduction.
To explore whether the observed responses could be
explained by changes in HIV-1 RNA metabolism, abun-
dance of HIV-1 US and MS RNAs was measured using
qRT–PCR. Consistent with the increased production of
Gag, hnRNP A2 depletion resulted in a marked increase
in US viral RNA levels (Figure 2). However, no changes in
MS HIV-1 RNAs were detected. In contrast, despite
altering viral protein expression, depletion of hnRNP A1
or D resulted in no signiﬁcant changes in abundance of
either viral RNA.
In addition to the relative abundance of HIV US and
MS RNAs, changes in HIV-1 gene expression could also
be elicited by alterations in the pattern of splice site use
within each class (SS and MS) of spliced viral RNA.
HIV-1 US RNA undergoes extensive alternative splicing
to generate over 40 mRNAs, some of which are illustrated
in Supplementary Figure S4. The primer sets used for the
qRT–PCR could not detect any shifts in splice usage
within individual viral RNA classes. Consequently,
further analysis was performed using primers that
ampliﬁed individual classes (MS, 1.8kb or SS, 4kb) of
viral RNA to analyze for possible changes in splice site
usage (Figure 3). For both MS and SS viral RNAs,
only depletion of hnRNP A1 induced reproducible alter-
ations in splice site usage. Increases in the level of Tat1/
Tat2, Nef3/Nef5 and Env5 products is consistent with
enhanced usage of the splice acceptors (SA) SA1, SA2
and SA3, previously shown to be regulated by direct
binding of hnRNP A1 (3).
Depletion of hnRNP D alters HIV-1 RNA subcellular
distribution
In absence of changes in HIV-1 RNA abundance or
splicing upon hnRNP D depletion that could explain the
reduced expression of Gag and Env, the effect of the treat-
ment on viral RNA subcellular distribution was examined
(Figure 4). Cells were treated with the indicated siRNA
[targeting hnRNP A2 or all hnRNP D isoforms (Figure
4A)] and subsequently separated into nuclear and cyto-
plasmic fractions. Abundance of US, SS and MS viral
RNAs was subsequently determined by qRT–PCR.
Treatment with scrambled (scr) or anti-hnRNP A2
siRNAs had only slight effect on the distribution of viral
RNAs (Figure 4B). In contrast, depletion of hnRNP D
resulted in reduced cytoplasmic accumulation of US and
SS HIV-1 RNAs but no alteration in distribution of MS
3666 Nucleic Acids Research, 2012,Vol.40, No. 8viral RNAs. Subsequent analysis of the subcellular frac-
tions for the presence of U6 snRNA and tRNA conﬁrmed
the quality of the fractionation procedure (Figure 4C).
Since analysis (Figure 2) did not detect any changes in
abundance of viral RNAs in response to hnRNP D deple-
tion, these ﬁndings are consistent with a requirement of
hnRNP D for export of Rev-dependent HIV-1 RNAs to
the cytoplasm.
Figure 1. Effect of hnRNP depletion on HIV-1 gene expression. (A) Schematic of HIV-1 FSGagGFP provirus, generated by fusion of GFP to the
C-terminus of Gag, resulting in the deletion of PR and a portion of RT. Construct was transduced into HeLa cells and stable lines isolated by FACs.
(B) To assay the effects of siRNA treatments on expression of the target protein, HeLa FSGagGFP cells were treated as outlined in ‘Materials and
Methods’ section with none (Mc), scrambled (Ctr) or the indicated siRNA and effect on target protein expression monitored 48–72h after treatment.
Cells were harvested and levels of expression of the target protein analyzed by western blot. To normalize for protein loading, blots were subse-
quently probed with anti-tubulin antibody (tubulin) Shown are representative blots of the treated samples. Asterisk marks the position of a
crossreactive band for the anti-hnRNP D antibody. (C) Seventy-two hours following treatment of HeLa FSGagGFP cells with siRNAs to the
targeted protein, cells were harvested and western blots probed to detect levels of expression of HIV-1 Env (gp160, gp120) or GagGFP. To normalize
for possible loading variation, blots were subsequently probed for tubulin. (D) To measure effect of hnRNP depletion on HIV-1 virus release, HeLa
FSGagGFP cells were treated with indicated siRNAs and, 72h post-treatment, media harvested and levels of virion production determined by p24
ELISA. Shown are the results from more than three independent assays, asterisk denoting values determined to be signiﬁcantly different from
controls [mock, luciferase (luc), or scrambled (scr) siRNA at a P<0.05].
Nucleic Acids Research,2012, Vol.40, No. 8 3667HIV-1 induces a shift in hnRNP D/AUF1 subcellular
distribution
The determination that hnRNP D plays a role in
regulating HIV-1 RNA metabolism led us to investigate
the effect of this virus on the function of this host factor.
Examination of cells with or without HIV-1 revealed a
marked alteration in the subcellular distribution of
hnRNP D; from being predominately nuclear to marked
accumulation in the cytoplasm (Figure 5A mock versus
+HIV-1). Parallel staining for HIV-1 genomic RNA and
Gag protein indicated partial overlap. To investigate
whether all isoforms of hnRNP D were equally affected,
assays were repeated but nuclear and cytoplasmic frac-
tions were prepared by detergent lysis and components
analyzed by western blotting. As shown in Figure 5B,
quality of fractionation was conﬁrmed by blotting for
the presence of nucleolin (nuclear marker) or GAPDH
(cytoplasmic marker). Blotting determined that, of the
hnRNP D isoforms detected in the cell, both p45 and
p42 were present at approximately equal levels in the
nuclear fractions, but there was a selective accumulation
of the p42 isoform in the cytoplasm upon HIV-1 infection.
The presence of hnRNP D in the nuclear fraction of all
samples is explained by the design of this experiment in
which hnRNP D from untransfected cells contribute sig-
niﬁcantly to the western blot signal in this fraction.
To further explore the basis for the alteration in hnRNP
D shift in subcellular distribution upon viral infection, its
ability to interact with the HIV-1 proteins was examined.
Lysates from mock or infected cells were immunopre-
cipitated with anti-hnRNP D antibody and precipitates
probed for the presence of HIV-1 Gag. As shown in
Figure 6, in the presence or absence of RNase treatment,
Gag (p55) was detectable in the hnRNP D complexes,
indicating that these factors interact independent of RNA.
Isoforms of hnRNP D have different effects on HIV-1
gene expression
With the determination that hnRNP D is required for
HIV-1 structural protein expression, we investigated
which domains of the protein were essential for this
activity. As outlined in Figure 7A, four different
isoforms of hnRNP D (p37, p40, p42 and p45) exist,
generated by alternative inclusion/exclusion of exons 2
and 7 (27). To study whether the different isoforms
varied in their capacity to regulate HIV-1 gene expression,
epitope tagged versions were transfected into cells and
their expression determined. All isoforms were found to
express at equivalent levels upon transfection (Figure 7B).
To analyze the effect of overexpression of the different
hnRNP D isoforms on HIV-1 gene expression, a second
cell line was generated (HeLa HIVrtTAmls) (20). Given
that <100% of cells were likely to be transfected with the
expression vectors, we created a cell line in which only
cells taking up plasmid expressed the endogenous
provirus. To achieve this end, a modiﬁed form of the
HIV-1 provirus (HIVrtTA) was used, differing from
wild-type virus by insertion of Tet O operator sites into
the U3 region of the HIV-1 LTR and replacement of the
nef gene with the rtTA (reverse tetracycline transactivator)
reading frame (18). Consequently, HIV-1 gene expression
is dependent either on addition of doxycycline to the
medium (to activate rtTA) or transfection with the consti-
tutively active tTA activator (21). The HIV-1 rtTA
provirus was further modiﬁed by deletion of the RT and
IN genes to render the virus replication incompetent
(Supplementary Figure S5).
To examine the effect of hnRNP D isoforms on viral
gene expression, the HeLa HIVrtTAmls cell line was
transfected with expression vector for one of the
isoforms along with expression vectors for the tTA acti-
vator (to induce expression of the endogenous HIV-1
provirus) and secreted alkaline phosphatase (SEAP, to
monitor transfection efﬁciency/pleiotropic effects).
Analysis of HIV-1 gene expression revealed marked dif-
ferences in the effect of the hnRNP D isoforms on HIV-1
gene expression; p37 and p40 inhibiting Gag (p24) expres-
sion while overexpression of p45 and p42 increased expres-
sion or had no signiﬁcant effect, respectively (Figure 7C).
In contrast, overexpression of the different hnRNP D
isoforms had only a limited effect on SEAP expression
with only p40 generating a slight but reproducible reduc-
tion in SEAP levels (Figure 7D). Consistent with the in-
hibitory effect of p37/p40 on HIV-1 Gag expression,
overexpression of both of these hnRNP D isoforms sig-
niﬁcantly reduced HIV-1 US RNA levels (Figure 8A).
In contrast, p42/p45 had no or little effect on HIV-1 US
RNA accumulation but led to a slight reduction in HIV-1
MS RNA abundance comparable to that seen with p37.
Figure 2. Effect of hnRNP Depletion on HIV-1 RNA Levels.
(A) Schematic of HIV-1 provirus indicating the position of the
primers used for qRT–PCR analysis. (B) Seventy-two hours
post-treatment with indicated siRNAs, HeLa FSGagGFP cells were
harvested and total RNA extracted. To measure the effect of treat-
ments on HIV-1 RNA levels, abundance of US, 9kb and MS, 1.8kb
HIV RNAs was determined by qRT–PCR and values normalized to
actin mRNA levels in each cDNA preparation. Shown is the average of
more than three independent assays, asterisk denoting values
determined to be signiﬁcant at a P<0.05.
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stability, the possibility existed that the effects observed
upon overexpression of individual hnRNP D isoforms
were the result of selective regulation of HIV-1 RNA sta-
bility. To directly test this possibility, cells were trans-
fected with hnRNP D expression vectors as outlined
above and 48h later, RNA decay initiated by addition
of a-amanitin. As shown in Figure 8B and C, analysis of
the decay kinetics of viral US and MS RNAs revealed that
there was no change in rate of decay under the conditions
tested that could solely account for the differences in viral
RNA accumulation observed.
Selective depletion of hnRNP D p45 and p42 inhibits
HIV-1 Gag and Env expression
Based on the differing effects of the hnRNP D isoforms on
HIV-1 expression, it is possible that altering the relative
abundance of these isoforms could also affect HIV-1 gene
expression, to test this hypothesis, selective depletion of
p45 and p42 was performed using siRNA directed to exon
7 of hnRNP D in the context of the HeLa FSGagGFP cell
line. As shown in Figure 9, treatment of cells with siRNA
directed against exon 7 resulted in loss of p45 and some
reduction in the band corresponding to p42/p40. Parallel
analysis of the effect of this treatment on HIV-1 Gag, Env
and Rev protein levels determined that siD exon 7 siRNA
yielded a reduction in Gag and Env levels equivalent to
siRNA targeting all hnRNP D isoforms. In contrast, no
change in Rev expression was detected under any of the
conditions tested.
DISCUSSION
Recent high-throughput screens have highlighted the de-
pendence of HIV-1 on host cell factors (1), one screen
alone indicating the involvement of  250 host proteins
in facilitating HIV-1 replication from entry to assembly
and release (28). Of the factors affecting HIV-1 replication
described in the genome wide screens completed to date
(28–31), hnRNP F and U were the only hnRNPs indicated
as affecting HIV-1 replication and only in one of the four
screens. However, several groups have implicated
members of the hnRNP protein family in regulating
multiple facets of viral RNA metabolism including
splicing (hnRNP A1, H) (3,6), polyadenylation (hnRNP
U) (32), cytoplasmic transport (hnRNP A2) (14,15), or
translation (hnRNP E1) (16). Many of these studies
were performed in the context of in vitro assays, HIV
reporter vectors or using transient transfection of
proviral DNA into cells. In an effort to evaluate the role
Figure 3. Effect of hnRNP depletion on HIV-1 RNA splice site selection. (A) Schematic of HIV-1 provirus with the position of PCR primers used to
amplify 2- and 4-kb HIV RNAs shown. Effect of hnRNP depletion on HIV-1 2kb (B) and 4kb (C) splice-site selection. cDNA was prepared from
total RNA extracted from HeLa FSGagGFP cells treated with the indicated siRNA, radiolabeled amplicons generated and fractionated on
denaturing polyacylamide gels. Shown on the left are representative gels and at the right, the quantitation of changes in viral RNAs, upon
hnRNP A1 depletion summarizing multiple assays. Asterisks denote values deemed signiﬁcant from control (scr) at a P<0.05.
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cation under conditions that more accurately reﬂect the
replication process (i.e. low copy number, integrated
provirus), we carried out analyses using the stably
transduced HeLa FSGagGFP cell line. Of the six
proteins examined (hnRNP A1, A2, D, H, I, K), depletion
of three (hnRNP A1, A2 or D) was observed to generate
reproducible changes in HIV-1 gene expression.
Previous data had implicated hnRNP A1 as playing
a key role in regulating HIV-1 splicing through its
interaction with multiple ESS elements (ESSV, ESS2,
ESS3, ISS) located throughout the viral genome (3).
Mutational inactivation of some of these ESSs lead to
perturbation in HIV-1 RNA splicing, the most severe
being ESSV, mutation of which leads to dramatic over-
splicing of viral RNA (11). Previous studies examining the
effect of hnRNP A1 depletion on viral RNA processing
and expression had yielded contrasting results; one linking
hnRNP A1 depletion with reduced Gag expression
and virus release while the other determined that loss of
hnRNP A1 increased Gag expression (15,33). Differences
in reported effects could be attributed to cell type speciﬁc
effects. Data in this report determined that loss of hnRNP
A1 leads to increased Gag and Env expression associated
with little or no increase in abundance of the HIV-1
RNAs. Subsequent analysis of splice-site selection (MS
and SS viral RNAs) upon hnRNP A1 depletion revealed
increase accumulation of nef3, nef5, tat1 and tat2 RNAs
consistent with enhanced use of splice sites [e.g. SA1, SA2
and SA3 (see Supplementary Figure S4)] known to be
regulated by ESSs that interact with hnRNP A1 (3).
Effects on splice-site usage are greater in our experiments
than previously reported possibly due to the reduced copy
number of provirus in the cells (previous assays had used
transient transfection of provirus rather than integrated
provirus). It is of note that, despite the signiﬁcant
Figure 4. Effect of hnRNP A2/D depletion on HIV-1 RNA subcellular distribution. HeLa FSGagGFP cells were untreated (mock), treated with
control (scrambled, scr) or siRNA to the target hnRNP (siA2, siD). Three days post-transfection, cells were harvested and either total protein
extracted or cells lysed, nuclear and cytoplasmic fractions prepared and RNA extracted. As shown in (A), western blot conﬁrmed depletion of the
target protein (asterisk marks the position of a crossreactive band for the anti-hnRNP D antibody). Subsequent analysis of HIV-1 US, SS and
MSRNA abundance in each fraction was carried out by qRT–PCR (B). Shown is the summary of cytoplasmic/nuclear ratio for more than threee
independent assays, asterisks denoting values deemed signiﬁcant at a P<0.05. (C) To verify the quality of the fractionations, northern blots of total
RNA from each fraction were prepared and probed for the presence of either U6 snRNA (nuclear) or tRNA (cytoplasmic).
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was no signiﬁcant change in US versus MS HIV RNA
abundance (Figure 2). This observation indicates that,
while hnRNP A1 may affect splice site choice, it does
not regulate the overall efﬁciency of viral RNA splicing.
In the absence of changes in US RNA levels upon hnRNP
A1 depletion, the observed increase in GagGFP expres-
sion raises the possibility that hnRNP A1 may also play a
secondary role in either the transport or translation of
HIV-1 RNAs. Within the nucleus, binding of hnRNP
A1 could act to sequester the viral RNA from
Rev-mediated export. If true, reduced hnRNP A1 levels
would render a greater fraction of incompletely spliced
HIV-1 RNA available for export. Furthermore, consistent
with a role for hnRNP A1 in the cytoplasmic metabolism
of viral RNAs, previous studies have demonstrated that
HIV-1 infection induces a shift in the subcellular localiza-
tion of hnRNP A1 from the nucleus to the cytoplasm due
to an inhibition of import into the nucleus (24).
Of the factors whose depletion lead to increased HIV
gene expression, loss of hnRNP A2 had the greatest effect.
In contrast to hnRNP A1, loss of hnRNP A2 resulted in
little to no change in the usage of individual splice sites.
However, in contrast to previous reports, elevated Gag
protein expression was mirrored by an increase in the cor-
responding RNA (15,33). This difference again might
Figure 5. HIV-1 induces a shift in hnRNP D subcellular distribution. (A) HeLa cells were transfected with either a control plasmid (pcDNA3, mock)
or pNL4-3 (+HIV-1). Twenty-four hours post-transfection, cells were ﬁxed and processed as outlined in ‘Material and Methods’ section to allow
detection of US HIV-1 RNA (vRNA, green), hnRNP D (RNPD, red) and HIV-1 Gag (Gag, blue). Shown are representative samples of the
distribution patterns observed. (B) Cells were transfected as above and either total or nuclear and cytoplasmic fractions prepared. Fractions were
subsequently separated on SDS–PAGE gels, blotted and probed with antibodies to HIV-1 Gag (Gag, p24) or hnRNP D (p45, p42, p40, p37). Quality
of fractionation was conﬁrmed by probing blots for the presence of nucleolin (nuclear) or GAPDH (cytoplasmic) in all fractions.
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the case of transient transfection, low for integrated
provirus) among the different studies. The increased abun-
dance of US viral RNAs in the absence of any correspond-
ing changes in MS HIV RNA suggests that the loss of
hnRNP A2 is not inhibiting splicing but may be affecting
RNA stability. The failure to detect any signiﬁcant
changes in viral RNA distribution between nucleus and
cytoplasm upon loss of hnRNP A2 indicates that this
factor does not affect export of viral RNA from the
nucleus. In light of data implicating hnRNP A2 in
HIV-1 RNA trafﬁcking (15), depletion of this factor
could reduce US HIV-1 RNA packaging into virions, re-
sulting in its accumulation in the cytoplasm and engage-
ment with the translation apparatus.
Of the hnRNPs screened in our assay, only loss of
hnRNP D resulted in a signiﬁcant reduction in HIV-1
gene expression. Localized predominately to the nucleus,
all isoforms of hnRNP D are capable of shuttling between
the nucleus and cytoplasm (19). hnRNP D/AUF1 was ﬁrst
identiﬁed in other systems to play a role in regulating
stability of AU-rich element (ARE) mRNAs (34,35).
However, subsequent research has indicated that hnRNP
D can have differing effects on gene expression depending
on the mRNA being examined; affecting transcriptional
activation (Epstein Barr virus) (36), mRNA stability
(c-myc, c-fos, GM-CSF) (35) or translation (c-myc, ribo-
somal L32) (37,38). Despite its role in regulating mRNA
stability, only a subset of cellular mRNAs bound by
hnRNP D undergo changes in abundance upon hnRNP
D depletion or overexpression, (39). These ﬁndings
suggest that hnRNP D’s role in regulating mRNA metab-
olism is context dependent. Adding to the complexity is
the determination that the four isoforms of hnRNP D
(differing in the inclusion of exons 2 and 7) vary in their
relative expression among various tissues [with highest
p45/p42 levels in lymphocytes (40)] and capacity to
regulate ARE–RNA metabolism (19,41,42). The
isoforms can function in an antagonist fashion (43). In
the experiments reported here, western blots indicated en-
dogenous expression of predominately p40, p42 and p45
in the cell lines used, depletion of which resulted in
reduced HIV Gag and Env synthesis, an effect attributable
to decreased accumulation of the corresponding RNAs in
Figure 7. Effect of hnRNP D isoforms on HIV-1 gene expression. (A)
Schematic of hnRNP D/AUF1 isoforms indicating the differential in-
clusion of exons 2 and 7. (B) Analysis of hnRNP D Isoform
Expression. HeLa HIVrtTAmls cells were transfected with vectors
expressing FLAG-tagged versions of each hnRNP D isoform, Cells
were harvested 48h post-transfection, total cell lysate fractionated on
SDS–PAGE gels, blotted and probed with both anti-FLAG and
anti-tubulin antibodies. (C and D) HeLa HIVrtTAmls cell line was
transfected with vectors expressing individual hnRNP D isoforms, tTA
expression cassette (+tTA) and secreted alkaline phosphatase (SEAP).
About 48–72h post-transfection, cell and medium were harvested and
analyzed. HIV gene expression was monitored by p24 ELISA (C) while
effects on SEAP expression were determined by enzymatic assay (D).
Asterisks denote results found to be signiﬁcantly different
(P value<0.05) from control (+tTA).
Figure 6. Interaction of hnRNP D with HIV-1 Gag. HeLa cells were
transfected with either pcDNA3 (mock) or pNL4-3 (+HIV-1).
Twenty-four hours post-transfection, cells were harvested, lys-
ates prepared and either used directly or treated with RNase A
(+RNase A) prior to use. To examine interaction of hnRNP D with
HIV-1 Gag, hnRNP D was immunoprecipitated from the lysates, pre-
cipitates fractionated on SDS PAGE gels and blots probed with either
anti-hnRNP D (p45, P42, p40, p37) or anti-HIV-1 Gag antibody.
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in subcellular distribution of MS viral RNAs suggests that
hnRNP D has a role in either export of Rev-dependent
RNAs or their cytoplasmic stability. Although this obser-
vation indicates a role for hnRNP D in mRNA export
versus its known activity in regulating cytoplasmic
mRNA metabolism, recent studies determined that
hnRNP D needs to interact with target mRNA in the
nucleus to regulate mRNA cytoplasmic stability, suggest-
ing that it may act to alter the composition of the RNP
(19,44). The absence of any change in HIV-1 US RNA
abundance upon hnRNP D depletion supports a role in
export. Consequently, hnRNP D may be involved
in altering nuclear RNP composition to subsequently
change mRNA metabolism in other cellular compart-
ments. The observed shift in hnRNP D distribution to
the cytoplasm upon HIV-1 infection is consistent with
the factor accompanying viral RNAs upon transport to
the cytoplasm. It is unclear whether the same mechanism
by which HIV-1 alters hnRNP A1 subcellular distribution
(24) also accounts for the change in hnRNP D subcellular
distribution. The detection of some colocalization of
hnRNP D with US HIV-1 RNA and the interaction of
hnRNP D with Gag is consistent with hnRNP D being
part of the HIV-1 mRNP. This hypothesis has recently
been conﬁrmed by Kulin et al. who determined that
hnRNP D is part of the HIV-1 US RNP within the
nucleus (45).
Tests of the individual hnRNP D isoforms in the
context of our system determined that overexpression of
either p37 and p40 reduced HIV-1 Gag expression coinci-
dent with a reduction in abundance of viral US and MS
RNAs, the most affected being the US HIV-1 RNAs. In
contrast, overexpression of p45 or p42 slightly enhanced
Gag protein synthesis but without altering US viral RNA
abundance. Recent studies have demonstrated marked dif-
ferences between hnRNP D isoforms in their interaction
with RNA with p42 and p45 isoforms displaying an
enhanced capacity to oligomerize on target RNAs (46)
Of particular note in our analyses was the ﬁnding that
p42/p45 overexpression had effects similar to p37 on MS
viral RNA abundance, indicating that these factors affect
the various HIV-1 mRNAs in different ways. Such dis-
crimination could be achieved through recognition of
Figure 8. Effect of hnRNP D isoforms on HIV-1 RNA abundance and
stability. (A) HeLa HIVrtTAmls cell line was transfected with vectors
expressing hnRNP D isoforms p40 or p45, tTA expression cassette and
secreted alkaline phosphatase (SEAP). Forty-eight hours post-
transfection, total RNA was harvested and alterations in viral RNA
levels were determined by qRT–PCR for HIV-1 US and MS mRNAs.
Results shown are the average of a minimum of three independent
trials, asterisks indicating values that are signiﬁcant from control at
a P-value<0.05. (B and C) Forty-eight hours post-transfection,
a-amanitin (50mg/ml) was added and cells harvested at indicated
times. Total RNA was extracted and abundance of (B) US or (C)
MS viral RNAs determined by qRT–PCR as outlined in ‘Materials
and Methods’ section. Data was normalized using 18S rRNA as an
internal control.
Figure 9. Effect of selective depletion of hnRNP D p45/p42 on HIV-1
protein expression. HelaFSGagGFP cells were untreated (mock),
treated with scrambled siRNA (si-control), with siRNA to all hnRNP
D isoforms (si-D) or to hnRNP D p45/p42 isoforms (si-D exon 7).
About 48–72h post-treatment, cells were harvested and total protein
extracts analyzed for expression of hnRNP D (anti-hnRNP D),
GagGFP (anti-GFP), Env (gp160), Rev or tubulin.
Nucleic Acids Research,2012, Vol.40, No. 8 3673sequences unique to Gag or by the process of splicing
(used to generate the singly and MS viral RNAs) deposit-
ing a signal that alters their recognition/metabolism by
these factors (47). The responses observed were not uni-
versal as analysis of the cotransfected SEAP expression
vector failed to demonstrate signiﬁcant alterations in its
expression upon overexpression of the various hnRNP D
isoforms. Tests to measure effects of p45/p40 on viral
RNA stability did not detect alterations relative to
control that could explain the effects on US RNA abun-
dance. The differences in response to the individual
isoforms could reﬂect competition for common binding
sites on the affected RNA and/or the differential inter-
action of the particular isoform with other proteins
(27,48,49). The differences in activity of the hnRNP D
isoforms suggests that the predominance of p45 and p42
in the cell line used in this study [and in lymphocytes in
general (40)] creates a state supportive of HIV-1 gene ex-
pression. By shifting the equilibrium to increase p37 and
p40 levels, a non-permissive environment to the virus
could be generated (as achieved in our transient expression
assays). This hypothesis was validated in our system
(Figure 9) by selective depletion of the p45/p42 isoforms
resulting in reduced HIV-1 Gag and Env levels compar-
able to that seen upon depleting all hnRNP D isoforms.
The basis for the response observed is unclear but could be
due to changes in accessibility of RNA sequences to other
factors (HuR, TIAR) known to act competitively with
hnRNP D (35,37); altering hnRNP D abundance (up or
down) would perturb the equilibrium and alter the asso-
ciation of these factors with the viral RNA.
The characterization of hnRNP proteins whose deple-
tion either enhance or inhibit expression of the HIV-1
genome provides support for the hypothesis that replica-
tion of the virus is dependent on the balanced control of
viral RNA metabolism. Understanding the role of the in-
dividual host factors in each step of HIV-1 RNA process-
ing facilitates the identiﬁcation of unique bottlenecks that
could be targeted to suppress replication of HIV-1. The
demonstration that altering the abundance of factors such
as hnRNP D isoforms can dramatically alter HIV-1 gene
expression suggests that viral latency can be generated at
multiple levels. Furthermore, the differential effect of
hnRNP D depletion and overexpression on the abundance
and transport of the different classes (US, SS or MS) of
HIV-1 RNAs further supports the hypothesis that their
different patterns of processing confer distinct fates that
might be exploited to regulate HIV-1 replication (50).
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